ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 282 out of 2035

$429K Total Retail Price of All Prescriptions

Rank: 420 out of 2035

281 Patients Receiving at Least One Drug in Part D
48%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

36% of this provider’s 281 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

4% of this provider’s 4,402 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $63 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
HYDROCODONE-ACETAMINOPHEN 347 128 S3 1 2
SIMVASTATIN 333 192 2 1
METOPROLOL TARTRATE 316 193 3 8
FUROSEMIDE 307 155 4 7
AMLODIPINE BESYLATE 293 166 5 6
LISINOPRIL 213 122 6 3
OMEPRAZOLE 213 111 6 5
METFORMIN HCL 202 134 8 9
HYDROCHLOROTHIAZIDE 138 94 9 12
ISOSORBIDE MONONITRATE ER 128 89 10 32
ATORVASTATIN CALCIUM 122 66 11 13
LOSARTAN POTASSIUM 120 87 12 15
CARISOPRODOL 120 40 R 12 57
CLOPIDOGREL 116 71 14 30
TRAMADOL HCL 115 56 15 19
PROAIR HFA 106 51 16 31
PLAVIX 102 77 17 49
AZITHROMYCIN 102 41 17 39
MELOXICAM 101 58 19 56
RANITIDINE HCL 96 55 20 28
ACETAMINOPHEN-CODEINE 95 45 S3 21 52
CARVEDILOL 93 71 22 22
LEVOTHYROXINE SODIUM 82 59 23 4
PANTOPRAZOLE SODIUM 81 49 24 42
POTASSIUM CHLORIDE 78 54 25 18
PREDNISONE 77 49 26 36
IBUPROFEN 71 39 27 43
CYCLOBENZAPRINE HCL 70 24 R 28 64
CLONIDINE HCL 64 13 29 61
GABAPENTIN 63 47 30 14
GLIPIZIDE 63 56 30 54
TAMSULOSIN HCL 60 45 32 25
BUMETANIDE 60 30 32 79
VENTOLIN HFA 57 23 34 80
ATENOLOL 57 35 34 10
WARFARIN SODIUM 54 33 36 11
ZOLPIDEM TARTRATE 52 26 37 21
ACTOS 51 33 38 124
CELEBREX 51 43 38 104
LOSARTAN-HYDROCHLOROTHIAZIDE 50 31 40 47
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 23, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.